← Eichor
Condition: Conjunctivitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Conjunctivitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Phase 3 · 38 location(s) · Baxis Pharmaceuticals, Inc. · NCT06911424
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04198740
Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07309432
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Phase 3 · 77 location(s) · Dompé Farmaceutici S.p.A · NCT07519902
Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye
Phase N/A · 1 location(s) · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07634913
Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis
Phase 1/Phase 2 · 1 location(s) · Senju USA, Inc. · NCT07565103
Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms
NA · 1 location(s) · Universiti Sains Malaysia · NCT07273747
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vern
Phase 2 · 11 location(s) · Laboratoires Thea · NCT07169695
3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
Phase 3 · 1 location(s) · The University of Hong Kong · NCT06903884
RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
NA · 2 location(s) · University of North Carolina, Chapel Hill · NCT07322302
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT06686472
Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT07220408
THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06771908
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.